SCAND1 and prostate carcinoma: The anti-EMT and tumor-suppressive effects of SCAND1 overexpression in DU-145 cells are consistent with our previous report showing that SCAND1 overexpression inhibited tumor growth of PC-3 prostate cancer cells in vivo [28].